Search By Initial

Name Index L

• Lonafarnib (Catalog# : 16071008, Cas# : 193275-84-2)Lonafarnib is a farnesyl transferase inhibitor. Structurely, it is also a synthetic t
• LJI308 (Catalog# : 16070904, Cas# : 1627709-94-7)LJI308 is a potent, and pan-RSK(p90 ribosomal S6 kinase) inhibitor withIC50of 6 nM, 4
• LJH685 (Catalog# : 16070903, Cas# : 1627710-50-2)LJH685 is a potent pan-RSKinhibitor withIC50of 6 nM, 5 nM and 4 nM for RSK1, RSK2, an
• LX1606 (Hippurate) (Catalog# : 16062301, Cas# : 1137608-69-5)LX1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibi
• Lumateperone(ITI-007) (Catalog# : 632801, Cas# : 313368-91-1)ITI-007 is an investigational atypical antipsychotic which is currently under develop
• LGD-4033(Ligandrol) (Catalog# : 030907, Cas# : 1165910-22-4)LGD-4033, also known as VK5211 and Ligandrol, is an investigational selective androge
• LY-379268 (Catalog# : 011904, Cas# : 191471-52-0)Coming soon!
• Lefamulin acetate (Catalog# : 011808, Cas# : 1350636-82-6)Coming soon!
• Lefamulin (Catalog# : 011807, Cas# : 1061337-51-6)Coming soon!
• L-165041 (Catalog# : 011316, Cas# : 79558-09-1)Coming soon!
• Linsitinib (Catalog# : 010819, Cas# : 867160-71-2)Linsitinib is highly potent, orally efficacious and highly selective, dual ATP-compet
• Lestaurtinib (Catalog# : 010815, Cas# : 111358-88-4)Lesraurtinib is an orally bioavailable indolocarbazole derivative with antineoplastic
• LX7101 (Catalog# : 010802, Cas# : 1192189-69-7)LX7101 is a potent inhibitor of LIMK1/2, ROCK2 and PKA, with IC50 of 24/1.6, 10, and
• Loratadine (Catalog# : 010435, Cas# : 79794-75-5)Loratadine is a selective inverse peripheral histamine H1-receptor agonist with an IC
• LY2584702 free base (Catalog# : 122909, Cas# : 1082949-67-4)LY2584702 is an orally available inhibitor of p70S6K signaling; inhibits p70S6K and p
• LY2584702 tosylate (Catalog# : 122907, Cas# : 1082949-68-5)LY-2584702 tosylate salt is an orally available inhibitor of p70S6K signaling; inhibi
• L-779450 (Catalog# : 122835, Cas# : 303727-31-3)L-779450 is a potent, selective and ATP-competitive Raf kinase inhibitor (IC50 = 10 n
• LDN193189 Hydrochloride (Catalog# : 122830, Cas# : 1062368-62-0)LDN193189 Hydrochloride is a selective BMP signaling inhibitor, inhibits the transcri
• LCL161 (Catalog# : 122820, Cas# : 1005342-46-0)LCL161 is an orally bioavailable SMAC mimetic and inhibitor of Inhibitor of Apoptosis
• Lexibulin (Catalog# : 122803, Cas# : 917111-44-5)Lexibulin is an orally bioavailable small-molecule with tubulin-inhibiting, vascular-
• LY2228820 (Catalog# : 122509, Cas# : 862507-23-1)LY2228820 is a novel and potent p38MAPK inhibitor (the IC50 for p38MAPK and p38MAPK w
• LY2608204 (Catalog# : 122218, Cas# : 1234703-40-2)LY2608204 is a activator of glucokinase (GK) with EC50 of 42 nM.
• L-778123 hydrochloride (Catalog# : 121805, Cas# : 253863-00-2)L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and
• Laquinimod (Catalog# : 121506, Cas# : 248281-84-7)Laquinimod is an experimental immunomodulator developed by Active Biotech and Teva.
• LY2811376 (Catalog# : 121435, Cas# : 1194044-20-6)LY2811376 is a BACE1 inhibitor with marked Ab-lowering effects in animal models.
• LY2886721 (Catalog# : 121427, Cas# : 1262036-50-9)LY2886721 is an BACE inhibitor used for the treatment of Alzheimer's Disease.
• Linifanib (Catalog# : 121416, Cas# : 796967-16-3)Linifanib is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR, CSF-1R, F
• LY2090314 (Catalog# : 5121102, Cas# : 603288-22-8)LY2090314 (LY) is a glycogen synthase kinase 3 inhibitor with preclinical efficacy in
• LMK 235 (Catalog# : 120422, Cas# : 1418033-25-6)LMK 235 is a selective histone deacetylase (HDAC) 4 and HDAC5 inhibitor, which demons
• LDN-57444 (Catalog# : 110606, Cas# : 668467-91-2)LDN-57444 is a Uch-L1 inhibitor with Ki= 0.4 M. Ubiquitin carboxy-terminal hydrolase